Goebell H, Hotz J
Z Gastroenterol Verh. 1976(10):28-31.
Calcitonin in pharmacological dosage inhibits the secretion of enzymes in the human pancreas without influencing the production of fluid and bicarbonate. The degree of inhibition is the same in a juice stimulated by secretin alone and by secretin plus pancreozymin-cholecystokinin or caerulein. Thus the endogenous and the exogenously applied pancreozymin is inhibited in its action. The secretion of enzymes, which is induced cholinergically by carbamylcholine or insulin hypoglycemia, is not altered by calcitonin. The inhibitory action of CT is not counteracted by infusion of calcium thus showing that local depletion of calcium is not the mechanism of inhibition. Possible mechanisms are the direct interference with pancreozymin at the acinar cell and the inhibition of hormone-release from the pancreozyminproducing cells.
药理剂量的降钙素可抑制人胰腺中酶的分泌,而不影响液体和碳酸氢盐的产生。在仅由促胰液素刺激以及由促胰液素加胰酶泌素 - 胆囊收缩素或蛙皮素刺激产生的胰液中,抑制程度相同。因此,内源性和外源性应用的胰酶泌素的作用均受到抑制。由氨甲酰胆碱或胰岛素低血糖症通过胆碱能诱导的酶分泌不受降钙素影响。降钙素的抑制作用不会因输注钙而被抵消,因此表明局部钙耗竭不是抑制机制。可能的机制是在腺泡细胞处直接干扰胰酶泌素以及抑制产生胰酶泌素的细胞释放激素。